Brighton Jones’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-18,760
Closed -$107K – 1479
2026
Q2
$107K Buy
+18,760
New +$85.2K ﹤0.01% 1307

Other funds holding MYGN

Brighton Jones's MYGN Position: Q3 2026 in Review

Brighton Jones sold out of Myriad Genetics (MYGN) in Q3 2026, closing a stake of 18,760 shares — an estimated $107K sold.

Brighton Jones first reported a position in MYGN in Q2 2026 and held it in 1 quarter. The position peaked at $107K in Q2 2026. 176 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.

  • Brighton Jones reported no remaining Myriad Genetics position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 18,760 Myriad Genetics shares in Q3 2026, an estimated $107K.
  • Brighton Jones first reported a position in Myriad Genetics in Q2 2026 and held it in 1 quarter.
  • Brighton Jones's Myriad Genetics position peaked at $107K in Q2 2026.
  • 176 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.